99mTC-tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations

Cancer

Volumn 94, Issue 6, 2002, Pages 1796-1807

  Buccheri, Gianfranco ^a   Biggi, Alberto ^b   Ferrigno, Domenico ^a   Francini, Antonella ^b  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b Servizio di Medicina Nucleare   (United States)

Author keywords

99mTC tetrofosmin scintigraphy; Computed tomography; Lung carcinoma; Staging assessment; Treatment response evaluation

Indexed keywords

DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SCINTISCANNING; CANCER SURGERY; DIAGNOSTIC ACCURACY; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0037085644     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10394     Document Type: Article

References (60)

1. Tracer imaging in lung cancer
2. The role of iodine-123-tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer
3. Somatostatin receptor scintigraphy with (111-In-DTPA-D-Phe-1) and (1231-Tyr-3-)-octreotide: The Rotterdam experience with more than 1000 patients
4. 111In] pentetreotide, a radiolabelled somatostatin analogue
5. The value of octreotide scintigraphy in patients with lung cancer
6. Thallium-201 as a positive indicator for lung neoplasms: Preliminary experiments
7. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer
8. Tl-201 scintigraphy in the staging of lung cancer, breast cancer and lymphoma
9. Preoperative assessment for mediastinal involvement of lung cancer using Tl-201 SPECT
10. Effectiveness of planar image and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer
11. Visualization of lung cancer with 99Tcm-tetrofosmin imaging: A comparison with 201Tl
12. Detection of primary lung cancer with Tc-99m SestaMIBI
13. Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: Comparison with CT scan
14. Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT
15. Effectiveness of Tc-99m MIBI scintigraphy in diagnosing lung cancer
16. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging
17. History and status of tumor imaging with radiolabelled antibodies
18. 131I and 111In-labelled monoclonal antibody imaging of primary lung carcinoma
19. Antibody-guided diagnosis: An Italian experience on CEA-expressing tumours
20. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab′)2 fragments of anti-CEA monoclonal antibody FO23C5
21. Evaluation of primary lung cancer with indium-111 anti-carcinoembryonic antigen (type ZCE-025) monoclonal antibody scintigraphy
22. Detection of suspected primary lung cancer by scintigraphy with indium-111-anticarcinoembryonic antigen monoclonal antibodies (type FO23C5)
23. Imaging lung cancer by scintigraphy with indium-111 labeled F(ab′)2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5
24. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography
25. Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer
26. Focal pulmonary abnormalities: Evaluation with 18F fluorodeoxyglucose PET scanning
27. Evaluation of fiuorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
28. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: Comparison with FDG PET
29. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma
30. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease
31. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
32. Staging by positron emission tomography predicts survival in patients with nonsmall cell lung cancer
33. Nuclear medicine imaging in lung cancer: A plenty of possibilities
34. Nuclear medicine procedures in lung cancer
35. PET in lung cancer
36. Advances in pulmonary nuclear medicine
37. Evaluation of malignant and benign lung lesions with 99Tcm-tetrofosmin
38. Technetium-99m tetrofosmin uptake in lung cancer: Comparison with thallium-201
39. Pulmonary Tc-99m tetrofosmin imaging: Clinical experience with detecting malignant lesions and monitoring response to therapy
40. Detection of lung and chest tumours using 99Tcm-tetrofosmin: Comparison with 201Tl
41. Technetium-99m-tetrofosmin SPECT imaging of lung masses: A negative study
42. Revisions in the International System for Staging Lung Cancer
43. Reporting results of cancer treatment
44. Purposes, principles of staging
45. Predictive values of laboratory tests
46. Confidence intervals
47. Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
48. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer
49. Mediastinoscopy: A review of anatomical relationships and complications
50. Mediastinal assessment for staging and treatment of carcinoma of the lung
51. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis
52. Preoperative computed tomographic scanning for staging lung cancer
53. Diagnosis of mediastinal lymph node metastases in lung cancer
54. Lack of clinical significance of gallium-67 uptake in non-small cell lung cancer
55. Yield of total body GA-67 scintigraphy in the staging of non-small cell lung cancer
56. Anti-CEA immunoscintigraphy in the pre-operative thoracic assessment of lung cancer: A comparison with CT
57. Anti-CEA immunoscintigraphy in the mediastinal node preoperative assessment of lung cancer
58. Technetium-99m-tetrofosmin uptake in malignant lung tumours